Ignite Creation Date:
2025-12-24 @ 12:47 PM
Ignite Modification Date:
2025-12-28 @ 9:57 AM
Study NCT ID:
NCT02009761
Status:
TERMINATED
Last Update Posted:
2024-03-15
First Post:
2013-12-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Multiple Rising Does Study (Subcutaneous Doses) of BI 655064 in Male and Female Patients With Chronic Primary Immune Thrombocytopenic Purpura (ITP).
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-12-18
Start Date Type:
ACTUAL
Primary Completion Date:
2016-04-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-04-26
Completion Date Type:
ACTUAL
First Submit Date:
2013-12-09
First Submit QC Date:
None
Study First Post Date:
2013-12-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-09-26
Results First Submit QC Date:
None
Results First Post Date:
2024-03-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-29
Last Update Post Date:
2024-03-15
Last Update Post Date Type:
ACTUAL